These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Vindesine in the treatment of small cell anaplastic bronchogenic carcinoma. Osterlind K; Dombernowsky P; Sørensen PG; Hansen HH Cancer Treat Rep; 1981; 65(3-4):245-8. PubMed ID: 6263469 [TBL] [Abstract][Full Text] [Related]
45. Vindesine. A review of phase-II trials. Gralla RJ; Tan CT; Young CW Cancer Chemother Pharmacol; 1979; 2(4):271-4. PubMed ID: 455587 [TBL] [Abstract][Full Text] [Related]
46. Phase I evaluation of vindesine in children: a Southwest Oncology Group pilot study. Komp D; Vats T; Shepherd DA; Vietti T; Hoogstraten B; Haas CD Med Pediatr Oncol; 1980; 8(3):243-50. PubMed ID: 7193278 [TBL] [Abstract][Full Text] [Related]
47. [Phase II study of the treatment of CML blast crisis with vindesine and prednisone]. Jehn U; Mezger J Onkologie; 1984 Dec; 7(6):342-5. PubMed ID: 6396561 [TBL] [Abstract][Full Text] [Related]
48. Sequential combination of methotrexate and vindesine in previously treated children with acute leukemia. A phase I-II study. Miller LP; Hancock C; Miller DR; Chello PL; Sirotnak FM; Tan CT Am J Clin Oncol; 1984 Oct; 7(5):465-70. PubMed ID: 6594925 [TBL] [Abstract][Full Text] [Related]
50. Phase II trial of vindesine in advanced neoplastic disease. Stambaugh JE Cancer Treat Rev; 1980 Sep; 7 Suppl 1():75-9. PubMed ID: 7438126 [No Abstract] [Full Text] [Related]
51. Phase II trial of vindesine in breast cancer, lymphoma and other tumors: future directions. Miller TP; Jones SE; Chester AB; Dorr RT Cancer Treat Rev; 1980 Sep; 7 Suppl 1():81-6. PubMed ID: 7438127 [No Abstract] [Full Text] [Related]
52. Vindesine in the treatment of refractory haematological malignant diseases. Young GA; Jurd J; Vincent PC Med J Aust; 1985 Feb; 142(3):189-90. PubMed ID: 3969034 [TBL] [Abstract][Full Text] [Related]
53. Phase II trial of vindesine in patients with squamous cell cancer of the head and neck. Sledge GW; Clark GM; Griffin C; Mattox DE; Von Hoff DD Am J Clin Oncol; 1984 Jun; 7(3):209-11. PubMed ID: 6731343 [TBL] [Abstract][Full Text] [Related]
55. Vindesine in the treatment of malignant mesothelioma: a phase II study. Kelsen D; Gralla R; Cheng E; Martini N Cancer Treat Rep; 1983 Sep; 67(9):821-2. PubMed ID: 6883358 [TBL] [Abstract][Full Text] [Related]
56. Vindesine and high-dose cisplatin in the treatment of advanced non-small-cell lung cancer. Fuks JZ; Patel H; Van Echo DA; Hornedo J; Aisner J Med Pediatr Oncol; 1985; 13(2):73-7. PubMed ID: 4039026 [TBL] [Abstract][Full Text] [Related]
57. Vindesine: an effective agent in the treatment of non-small cell lung cancer. Furnas BE; Williams SD; Einhorn LH; Cobleigh MA Cancer Treat Rep; 1982 Sep; 66(9):1709-11. PubMed ID: 7116347 [TBL] [Abstract][Full Text] [Related]
58. Pharmacology, clinical efficacy and adverse effects of vindesine sulfate, a new vinca alkaloid. Cersosimo RJ; Bromer R; Licciardello JT; Hong WK Pharmacotherapy; 1983; 3(5):259-74. PubMed ID: 6359081 [TBL] [Abstract][Full Text] [Related]
59. [Phase II study of vindesine in patients with carcinoma of the lung and metastatic pulmonary tumor]. Shibuya M; Saijo N; Shimizu E; Eguchi K; Shinkai T; Tominaga K; Shimabukuro Z Gan To Kagaku Ryoho; 1982 Oct; 9(10):1808-13. PubMed ID: 6307176 [TBL] [Abstract][Full Text] [Related]
60. Therapeutic efficacy and pharmacokinetics of vindesine and vindesine-cisplatin in previously treated patients with non-small cell lung carcinoma. Fuks JZ; Egorin MJ; Aisner J; Van Echo DA; Ostrow S; Bachur NR; Wiernik PH Cancer Chemother Pharmacol; 1983; 10(2):104-8. PubMed ID: 6299598 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]